388 related articles for article (PubMed ID: 4748872)
1. Therapy of advanced gastrointestinal cancer with the nitrosoureas.
Moertel CG
Cancer Chemother Rep 3; 1973 May; 4(3):27-34. PubMed ID: 4748872
[No Abstract] [Full Text] [Related]
2. Possibilities and limitations of the cytostatic treatment of gastrointestinal carcinoma.
Trux F
Hepatogastroenterology; 1982 Jun; 29(3):130-3. PubMed ID: 7049880
[No Abstract] [Full Text] [Related]
3. Role of a nitrosourea (CCNU, NSC-79037) in advanced nonhematologic cancer.
Perloff M; Muggia FM; Ackerman C
Cancer Chemother Rep; 1974; 58(3):421-4. PubMed ID: 4841718
[No Abstract] [Full Text] [Related]
4. Walter Hubert lecture Chemotherapy of upper gastrointestinal carcinoma.
Moertel CG
Br J Cancer; 1976 Sep; 34(3):325-34. PubMed ID: 184809
[No Abstract] [Full Text] [Related]
5. Nitrosoureas: useful agents for the treatment of advanced gastrointestinal cancer.
Douglass HO; Lavin PT; Moertel CG
Cancer Treat Rep; 1976 Jun; 60(6):769-80. PubMed ID: 782699
[TBL] [Abstract][Full Text] [Related]
6. Therapy of advanced colorectal cancer with a combination of 5-fluorouracil, methyl-1,3-cis(2-chlorethyl)-1-nitrosourea, and vincristine.
Moertel CG; Schutt AJ; Hahn RG; Reitemeier RJ
J Natl Cancer Inst; 1975 Jan; 54(1):69-71. PubMed ID: 1117460
[TBL] [Abstract][Full Text] [Related]
7. 3-(Tetraacetyl glucopyranos-2-yl)-1-(2-chloroethyl)-1-nitrosourea, an antitumor agent with modified bone marrow toxicity.
Schein PS; McMenamin MG; Anderson T
Cancer Res; 1973 Sep; 33(9):2005-9. PubMed ID: 4353476
[No Abstract] [Full Text] [Related]
8. Sequential 1-(2-chloroethyl)-3-cyclohexyl-1-nitrosourea (NSC 79037) and 5-fluorouracil (NSC 19893) therapy of gastrointestinal cancer.
Moertel CG; Schutt AJ; Reitemeier RJ; Hahn RG
Cancer Res; 1972 Jun; 32(6):1280-2. PubMed ID: 5030827
[No Abstract] [Full Text] [Related]
9. The nitrosoureas--thoughts for the future.
Carter SK; Wasserman TH
Cancer Treat Rep; 1976 Jun; 60(6):807-11. PubMed ID: 954014
[No Abstract] [Full Text] [Related]
10. An overview of the status of the nitrosoureas in other tumors.
Carter SK
Cancer Chemother Rep 3; 1973 May; 4(3):35-46. PubMed ID: 4584034
[No Abstract] [Full Text] [Related]
11. Combination with 5-fluorouracil, methyl-CCNU and beta-2-deoxythioguanosine in advanced colo-rectal adenocarcinoma.
Cedermark BJ; Kaufman JH; Douglass HO; Mittelman A
Clin Oncol; 1977 Mar; 3(1):27-31. PubMed ID: 862274
[No Abstract] [Full Text] [Related]
12. Combination of constant-infusion 5-fluorouracil, methyl-CCNU, mitomycin C, and vincristine in advanced colorectal carcinoma.
Greco FA; Richardson RL; Shulman SF; Oldham RK
Cancer Treat Rep; 1978 Sep; 62(9):1407-8. PubMed ID: 688289
[No Abstract] [Full Text] [Related]
13. Phase II study of CCNU (NSC-79037) in the treatment of advanced gastrointestinal cancer.
Klaassen DJ; Rapp E
Cancer Chemother Rep; 1974; 58(5 Pt 1):667-9. PubMed ID: 4426046
[No Abstract] [Full Text] [Related]
14. Randomized prospective trial comparing 5-fluorouracil (NSC-19893) to 5-fluorouracil and methyl-CCNU (NSC-95441) in advanced gastrointestinal cancer.
Baker LH; Vaitkevicius VK; Gehan E
Cancer Treat Rep; 1976 Jun; 60(6):733-7. PubMed ID: 954013
[TBL] [Abstract][Full Text] [Related]
15. A controlled study of 5-fluorouracil versus 5-fluorouracil and methyl-CCNU in advanced gastrointestinal adenocarcinoma.
Abdallah AM; Soukop M; Bell G; Calman KC
Clin Oncol; 1977 Sep; 3(3):247-57. PubMed ID: 334430
[No Abstract] [Full Text] [Related]
16. The phase II study: some reflections, particularly concerning disseminated breast cancer.
Ahmann DL
Cancer Chemother Rep 3; 1972 May; 3(1):29-32. PubMed ID: 5049705
[No Abstract] [Full Text] [Related]
17. [The combination methyl-CCNU, vincristine, 5-fluorouracil and streptozotocin in the treatment of advanced colo-rectal adenocarcinoma].
Togni P; Sessa C; Varini M; Cavalli F
Schweiz Med Wochenschr; 1982 Jun; 112(26):930-3. PubMed ID: 6214002
[TBL] [Abstract][Full Text] [Related]
18. Methyl-CCNU (NSC-95441) in advanced colorectal carcinoma after failure of 5-fluorouracil (NSC-19893) therapy.
Cedermark BJ; Didolkar MS; Elias EG
Cancer Treat Rep; 1976 Mar; 60(3):235-8. PubMed ID: 769977
[TBL] [Abstract][Full Text] [Related]
19. Phase II trial of PCNU in advanced colorectal carcinoma. An Eastern Cooperative Oncology Group pilot study.
Earhart RH; Moertel C; Hahn RG; Woodhouse CL; Ramirez G; Engstrom PF
Am J Clin Oncol; 1984 Aug; 7(4):309-12. PubMed ID: 6741861
[TBL] [Abstract][Full Text] [Related]
20. Nitrosoureas in central nervous system tumors.
Walker MD
Cancer Chemother Rep 3; 1973 May; 4(3):21-6. PubMed ID: 4584033
[No Abstract] [Full Text] [Related]
[Next] [New Search]
